Core Viewpoint - The company, Zhejiang Dongwang Times Technology Co., Ltd., is forecasting a significant net loss for the year 2025, primarily due to increased competition and management changes in its subsidiaries, as well as legal issues related to guarantees provided for a real estate developer [2][4][7]. Group 1: Performance Forecast - The company expects to achieve a net profit attributable to shareholders of approximately -450 million yuan for the year 2025 [2][4]. - The forecasted net profit, excluding non-recurring gains and losses, is approximately -370 million yuan [5]. - The performance forecast period is from January 1, 2025, to December 31, 2025 [3]. Group 2: Previous Year Comparison - In the previous year, the total profit was -331.38 million yuan, with a net profit attributable to shareholders of -366.92 million yuan [6]. - The net profit attributable to shareholders, excluding non-recurring gains and losses, was -203.84 million yuan [6]. - The earnings per share for the previous year were -0.45 yuan [7]. Group 3: Reasons for Expected Loss - The expected loss is attributed to intensified competition in the park life service industry and changes in the core management team, leading to significant declines in net profits for subsidiaries Zhejiang Zhenglan Energy Technology Co., Ltd. and Chongqing Huixian Youce Technology Co., Ltd. [7]. - The company plans to recognize goodwill impairment provisions for these subsidiaries, estimated between 280 million yuan and 360 million yuan [7]. - The company has provided guarantees for Hangzhou Yirong Real Estate Development Co., Ltd., which are overdue and involved in litigation, with a principal debt amount of 281 million yuan, leading to a provision of approximately 171 million yuan for this guarantee [7]. Group 4: Revenue Expectations - The company anticipates total revenue of approximately 587 million yuan for 2025, with 2025 revenue from its subsidiary Dongwang Shuzhi Technology Co., Ltd. being classified as non-recurring [10]. - After excluding the impact of Dongwang Shuzhi, the expected revenue is approximately 385 million yuan, primarily from the operation and management of hot water supply systems by subsidiaries Zhenglan Energy and Huixian Youce [10].

Group 1 - The company expects a net profit attributable to shareholders of the parent company for 2025 to be between -480 million and -400 million yuan, indicating an increase in losses compared to the previous year [3] - The net profit excluding non-recurring gains and losses is projected to be between -490 million and -410 million yuan [3] - The previous year's net profit attributable to shareholders was -63.26 million yuan, with a total profit of -73.49 million yuan [4] Group 2 - The decline in profitability is attributed to changes in product and customer structure, as well as intensified market competition due to oversupply in the lithium battery industry, leading to lower product prices and reduced gross margin [6] - The company has conducted a comprehensive impairment test on inventory, resulting in increased asset impairment losses due to new inventory impairment provisions [6] - Difficulties in customer payments have lengthened accounts receivable aging, significantly increasing the provision for bad debts compared to the previous year [7] Group 3 - The company plans to enhance operational efficiency, optimize costs and expenses, improve customer structure, and strengthen collection efforts on accounts receivable to gradually increase gross margin and improve profitability [7]

Group 1 - The company expects to report a decline in operating performance for the year 2025 due to various factors including fluctuations in overseas market demand and intensified domestic industry competition [2] - The company has communicated with its accounting firm regarding significant matters related to the performance forecast, and there are no major disagreements between the two parties [1] - The company has faced quality issues with some raw materials, leading to increased expense provisions based on prudence, which negatively impacted the current performance [2] Group 2 - The performance forecast period is set from January 1, 2025, to December 31, 2025, with the company indicating a potential turnaround or upward trend in performance [1] - The preliminary forecast data has not been audited by the accounting firm, and the final financial data will be disclosed in the company's 2025 annual report [3]

Group 1 - The company forecasts a revenue range of 580 million to 660 million yuan for the year 2025, representing an increase of 14.70 million to 94.70 million yuan compared to the previous year, which is a year-on-year growth of 2.60% to 16.75% [2] - The projected net profit attributable to the parent company for 2025 is expected to be between -48 million and -68 million yuan [2] - The net profit attributable to the parent company, excluding non-recurring gains and losses, is forecasted to be between -78 million and -108 million yuan [3] Group 2 - The company reported a revenue of 565.30 million yuan for the year 2024, with a net profit attributable to the parent company of -52.32 million yuan [3] - The earnings per share for the previous year was -0.46 yuan [4] - The increase in product sales is attributed to the gradual recovery of the downstream consumer electronics industry, leading to revenue growth [4] Group 3 - The decline in the USD to RMB exchange rate has negatively impacted the net profit attributable to shareholders [5] - The reduction in bank interest rates has led to decreased investment income, affecting both net profit and net profit after excluding non-recurring gains and losses [5]

Group 1 - The company forecasts a net loss attributable to shareholders of the parent company for the year 2025, estimated between 80 million to 100 million yuan, representing an increase in loss of 22.73 million to 42.73 million yuan compared to the previous year, with a year-on-year increase in loss of 39.68% to 74.60% [3] - The net loss attributable to shareholders after deducting non-recurring gains and losses is also expected to be between 80 million to 100 million yuan, with a year-on-year increase in loss of 22.37 million to 42.37 million yuan, reflecting an increase of 38.82% to 73.53% compared to the previous year [3] - The previous year's net profit attributable to shareholders was a loss of 57.27 million yuan, with a total profit of -63.57 million yuan [5] Group 2 - The increase in losses is attributed to fluctuations in market demand for certain products, the production base in Jiaxing being in a ramp-up phase, and higher fixed costs per unit due to incomplete capacity release [7] - The company expects to achieve an operating income of 380 million to 400 million yuan in 2025, which represents a year-on-year growth of 12.08% to 17.98% [7] - Financial and management expenses have increased due to higher depreciation and interest costs associated with the Jiaxing project, along with costs from convertible bonds [7]

Group 1 - The company expects a significant decline in net profit for the fiscal year 2025, with the forecast period from January 1, 2025, to December 31, 2025 [2][3] - The anticipated net profit is projected to be negative, indicating a challenging financial outlook [3] - The company has communicated with its accounting firm regarding the earnings forecast, and there are no significant disagreements [3] Group 2 - The decline in net profit is attributed to multiple factors, primarily the adverse impact of changes in the international trade environment, which has led to a significant drop in sales [4] - The company plans to recognize an inventory impairment loss of approximately 10.6 million yuan due to market demand changes and accelerated product updates, which will negatively affect net profit [5] - The company has not recognized deferred tax assets related to its U.S. subsidiary, amounting to about 36.2 million yuan, due to uncertainties in future profitability, further reducing the consolidated net profit [6] Group 3 - The company aims to actively adjust its market strategy, optimize its global supply chain, strengthen cost control, and closely monitor international trade policy dynamics to enhance overall profitability and risk resilience [7]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002342 证券简称：巨力索具 公告编号：2026-004 巨力索具股份有限公司2025年度业绩预告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 一、本期业绩预计情况 1、业绩预告期间：2025年1月1日-2025年12月31日； 2、业绩预告情况：预计净利润为正值且属于扭亏为盈的情况。 （1）以区间进行业绩预告 ■ 本次业绩预告相关数据是公司财务部门初步测算的结果，未经会计师事务所审计；公司已就业绩预告有 关事项与会计师事务所进行预沟通，公司与会计师事务所在本次业绩预告方面不存在分歧。 三、业绩变动情况说明 报告期内，公司主营业务实现稳健增长，主要得益于冶金矿山、机械装备行业为代表的传统市场稳中有 增，同时公司不断自我调整产品结构，如：以新能源行业为代表的新兴领域需求持续旺盛，优化了公司 收入结构，实现了产量、销量、营业收入同步增长的同时，公司期间费率有所下降。 四、其他相关说明 本次业绩预告是公司财务部门初步测算的结果，未经会计师事务所审计，具体财务数据以公司披露的 2025年度报告为准。敬 ...

Core Viewpoint - The company, Luoxin Pharmaceutical Group Co., Ltd., anticipates a negative net profit for the fiscal year 2025, despite improvements in operational performance and a significant reduction in losses compared to the previous year [2][5]. Group 1: Performance Forecast - The performance forecast period is from January 1, 2025, to December 31, 2025, with an expected net profit in negative territory [1]. - The financial data related to this performance forecast has not been audited by the accounting firm, but preliminary discussions have taken place without any disagreements [2]. Group 2: Reasons for Performance Changes - The company continues to strategically focus on the pharmaceutical industry, particularly in the gastrointestinal field, with significant growth driven by its core innovative drug, Tegoprazan (brand name: Taixinzan) [3]. - The commercialization of Tegoprazan has progressed well, with new indications for "duodenal ulcers" and "eradication of Helicobacter pylori in conjunction with appropriate antibiotic therapy" added to the medical insurance directory, which is expected to enhance sales and operational efficiency [4]. Group 3: Overall Business Condition - The overall business condition for 2025 shows a positive improvement trend, with a significant reduction in losses year-on-year, primarily due to the successful commercialization of Tegoprazan and the diminishing negative impact from previous asset impairments [4]. - The company has recognized fair value losses related to financial liabilities from its investment in Shangyao Luoxin, which is a non-recurring loss, and the impact is expected to be one-time as the performance guarantee period has ended [5]. - The company has initiated procedures to dispose of loss-making businesses related to LeKang Pharmaceutical and Luoxin Anruo Weita, which will further reduce losses once completed [5].

Group 1 - The company expects a net profit attributable to shareholders of the parent company for 2025 to be between -480 million and -400 million yuan, representing a reduction in losses of 390.37 million to 470.37 million yuan, an increase of 44.85% to 54.04% compared to the previous year [3] - The expected net profit attributable to shareholders of the parent company, after deducting non-recurring gains and losses, is projected to be between -429 million and -358 million yuan, indicating a reduction in losses of 462.73 million to 533.73 million yuan, with a year-on-year increase of 51.89% to 59.85% [3] - The company's performance in 2024 showed a total profit of -991.61 million yuan, with a net profit attributable to shareholders of the parent company at -870.37 million yuan [5] Group 2 - The company has actively developed new products and expanded sales markets, resulting in a significant year-on-year increase in the sales volume of lithium iron phosphate, despite a decrease in the average price of lithium carbonate [6] - The company expects a reduction in the provision for inventory impairment due to improved inventory management and cost reduction measures, leading to a narrowing of overall performance losses compared to the previous year [6] - The company has adopted a pricing model for some lithium carbonate procurement, which has resulted in fair value changes being recognized as non-recurring gains and losses due to rapid price increases in the fourth quarter [6]

Group 1 - The company expects a negative net profit for the fiscal year 2025, covering the period from January 1, 2025, to December 31, 2025 [1] - The financial data related to the earnings forecast has not been audited by the accounting firm, but there are no disagreements between the company and the accounting firm regarding the earnings forecast [1][2] Group 2 - The company is actively adjusting its product strategy and working to reduce historical inventory from 2024 and earlier, which has impacted revenue and gross margin during the reporting period [2] - There has been an increase in impairment losses recognized during the reporting period due to accounting standards and a cautious approach [3] - The company experienced a significant decrease in asset disposal gains compared to the same period last year, where substantial gains were realized from property disposals [3]